Premier Biomedical Inc (BIEI)
0.0017
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Premier Biomedical Total Liabilities (Quarterly): 2.126M for March 31, 2018
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 1.934M |
| September 30, 2019 | 2.304M |
| June 30, 2019 | 2.298M |
| March 31, 2019 | 2.128M |
| December 31, 2018 | 2.312M |
| September 30, 2018 | 2.472M |
| June 30, 2018 | 2.203M |
| March 31, 2018 | 2.126M |
| December 31, 2017 | 2.820M |
| September 30, 2017 | 2.885M |
| June 30, 2017 | 6.505M |
| March 31, 2017 | 5.358M |
| December 31, 2016 | 0.6997M |
| September 30, 2016 | 0.8637M |
| June 30, 2016 | 0.8006M |
| March 31, 2016 | 0.3597M |
| December 31, 2015 | 0.4738M |
| Date | Value |
|---|---|
| September 30, 2015 | 0.5163M |
| June 30, 2015 | 0.4204M |
| March 31, 2015 | 0.3591M |
| December 31, 2014 | 0.1884M |
| September 30, 2014 | 0.0533M |
| June 30, 2014 | 0.06M |
| March 31, 2014 | 0.0208M |
| December 31, 2013 | 0.2745M |
| September 30, 2013 | 0.1801M |
| June 30, 2013 | 0.1477M |
| March 31, 2013 | 0.1977M |
| December 31, 2012 | 0.1192M |
| September 30, 2012 | 0.0603M |
| June 30, 2012 | 0.0354M |
| March 31, 2012 | 0.0136M |
| December 31, 2011 | 0.0031M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.934M
Minimum
Dec 2019
2.304M
Maximum
Sep 2019
2.179M
Average
2.298M
Median
Jun 2019
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.1989M |
| Shareholders Equity (Quarterly) | -1.927M |